Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
CEO’s 48-Hour Action Plan Context: I’ve just learned that our flagship chronic pain drug has a rare but serious liver failure risk (1 in 8,000 patients over 5 years), previously unknown. I have 48 hours until the board meeting and 72 hours until the earnings call.Read the full answer
You have a patient safety issue, not a PR issue. The 6 month regulatory reporting timeline is the formal process, not the ethical or legal obligation to act now. Waiting for more data while patients continue to be exposed is criminal negligence exposure, not risk mitigation.Read the full answer